Screening Fanconi anemia lymphoid cell lines of non-A, C, D2, E, F, G subtypes for defects in BRCA2/FANCD1.
Biallelic mutations in BRCA2/FANCD1 were recently recognized as a rare cause of Fanconi anemia (FA). Using immunodetection with an antiserum directed against the carboxyterminus of the BRCA2 protein, we screened 38 lymphoid cell lines from FA patients whom we could not previously assign, via retroviral complementation analysis, to any of six known FA complementation groups (FA-A, -C, -D2, -E, -F, or -G). Three of these 38 cell lines lacked the 380-kDa BRCA2 signal on immunoblots. DNA sequencing showed biallelic compound and truncating mutations in two of the immuno-negative cell lines, whereas a monoallelic frameshift mutation and an amino acid substitution were detected in the third cell line. Our data show that less than 10% of unassigned FA cell lines harbor truncating mutations in BRCA2/FANCD1. This finding strongly suggests the existence of (an) additional, as yet unknown FA gene(s).
Department of Human Genetics, University of Würzburg, Würzburg, Germany.
H
H
Popp
R
R
Kalb
A
A
Fischer
S
S
Lobitz
I
I
Kokemohr
H
H
Hanenberg
D
D
Schindler
D002461:Cell Line, Transformed; D045744:Cell Line, Tumor; D004252:DNA Mutational Analysis; D005199:Fanconi Anemia / Q000145:classification / Q000235:genetics*; D024522:Genes, BRCA2; D006801:Humans; D008214:Lymphocytes / Q000166:cytology; D009154:Mutation